We are live on ! Find out more
BFA

BlackRock Fund Advisors Portfolio holdings

AUM $542B
1-Year Est. Return 18.13%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+18.13%
3 Year Est. Return
+41.39%
5 Year Est. Return
10 Year Est. Return
AUM
$487B
AUM Growth
+$34.3B
Cap. Flow
+$16.7B
Cap. Flow %
3.43%
Top 10 Hldgs %
9.71%
Holding
4,391
New
38
Increased
3,504
Reduced
475
Closed
106

Sector Composition

Rank Sector Weight
1 Healthcare 13.49%
2 Technology 12.95%
3 Financials 12.48%
4 Industrials 10.43%
5 Consumer Discretionary 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNDO icon
3601
Mind CTI
MNDO
$21.6M
$96K ﹤0.01%
44,097
-448
-1% -$965
FLNA
3602
Filana Therapeutics
FLNA
$42M
$96K ﹤0.01%
13,783
-5
-0% -$83
HSTO
3603
DELISTED
Histogen Inc. Common Stock
HSTO
$95K ﹤0.01%
237
-1
-0.4% -$408
MGT
3604
DELISTED
MGT CAPITAL INVESTMENTS INC COM NEW (DE)
MGT
$95K ﹤0.01%
47,065
-478
-1% -$1.53K
OESX icon
3605
Orion Energy Systems
OESX
$38.9M
$94K ﹤0.01%
7,088
-6
-0.1% -$80
MARA icon
3606
Marathon Digital Holdings
MARA
$3.83B
$91K ﹤0.01%
2,027
-2
-0.1% -$93
AIQ
3607
DELISTED
Alliance Healthcare Services
AIQ
$91K ﹤0.01%
13,283
+89
+0.7% +$554
CIZN
3608
DELISTED
Citizens Holding Co.
CIZN
$91K ﹤0.01%
3,925
+25
+0.6% +$569
GALT icon
3609
Galectin Therapeutics
GALT
$230M
$89K ﹤0.01%
78,879
-76
-0.1% -$135
RVP icon
3610
Retractable Technologies
RVP
$20.1M
$87K ﹤0.01%
33,815
+1,745
+5% +$4.42K
IIN
3611
DELISTED
IntriCon Corporation
IIN
$87K ﹤0.01%
15,116
+3,519
+30% +$16.8K
AEMD icon
3612
Aethlon Medical
AEMD
$1.4M
$86K ﹤0.01%
1
SYRE icon
3613
Spyre Therapeutics
SYRE
$8.5B
$84K ﹤0.01%
526
+85
+19% +$11.8K
PTX
3614
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$84K ﹤0.01%
13,514
+12,765
+1,704% +$78.7K
REN
3615
DELISTED
Resolute Energy Corporaton
REN
$84K ﹤0.01%
3,227
+344
+12% +$4.95K
BZUN
3616
Baozun
BZUN
$179M
$83K ﹤0.01%
5,472
+2,898
+113% +$30.4K
LOAN
3617
Manhattan Bridge Capital
LOAN
$48M
$83K ﹤0.01%
11,643
-53
-0.5% -$318
EEI
3618
DELISTED
Ecology and Environment
EEI
$82K ﹤0.01%
8,327
-82
-1% -$833
RIGP
3619
DELISTED
Transocean Partners LLC
RIGP
$82K ﹤0.01%
6,652
-329
-5% -$3.86K
NTIP icon
3620
Network-1 Technologies
NTIP
$37.5M
$80K ﹤0.01%
29,484
+2,465
+9% +$6.6K
PULM icon
3621
Pulmatrix
PULM
$6.1M
$80K ﹤0.01%
244
+160
+190% +$59.9K
MSON
3622
DELISTED
Misonix Inc
MSON
$80K ﹤0.01%
14,892
+2,205
+17% +$13.3K
LOV
3623
DELISTED
Spark Networks SE American Depositary Shares
LOV
$79K ﹤0.01%
49,790
+153
+0.3% +$254
FLL icon
3624
Full House Resorts
FLL
$83.4M
$78K ﹤0.01%
43,476
+16,504
+61% +$31K
SIF icon
3625
SIFCO Industries
SIF
$167M
$78K ﹤0.01%
7,888
-17
-0.2% -$136

Similar funds

BlackRock Fund Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, BlackRock Fund Advisors held 4,391 positions worth $487B, up 7.6% from $453B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

BlackRock Fund Advisors deployed $16.7B of net new capital in Q3 2016, opening 38 new positions and adding to 3,504 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 411,999 shares worth $539M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $725M trimmed.

  • BlackRock Fund Advisors's largest Q3 2016 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 411,999 shares worth $539M.
  • BlackRock Fund Advisors added most to AT&T in Q3 2016, an estimated $676M increase.
  • BlackRock Fund Advisors's biggest Q3 2016 reduction was iShares MSCI EAFE ETF, cutting an estimated $725M.
  • BlackRock Fund Advisors fully exited EMC CORPORATION in Q3 2016, selling an estimated $723M.
  • BlackRock Fund Advisors's ten largest holdings make up 9.7% of its $487B portfolio in Q3 2016.
  • BlackRock Fund Advisors opened 38 new positions and closed 106 in Q3 2016.
  • BlackRock Fund Advisors's portfolio value rose 7.6% quarter-over-quarter to $487B.

Based on BlackRock Fund Advisors's 13F filing for Q3 2016, filed 8 Nov 2016.